Cingulate Stock Buy Hold or Sell Recommendation
| CING Stock | USD 4.70 0.02 0.42% |
Given the investment horizon of 90 days and your highly speculative risk level, our recommendation regarding Cingulate is 'Hold'. Macroaxis provides Cingulate buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CING positions.
Check out Cingulate Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide. Note, we conduct extensive research on individual companies such as Cingulate and provide practical buy, sell, or hold advice based on investors' constraints. Cingulate. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Cingulate |
Execute Cingulate Buy or Sell Advice
The Cingulate recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Cingulate. Macroaxis does not own or have any residual interests in Cingulate or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Cingulate's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Very Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Cingulate Trading Alerts and Improvement Suggestions
| Cingulate generated a negative expected return over the last 90 days | |
| Cingulate has high historical volatility and very poor performance | |
| Cingulate has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (23.53 K) with loss before overhead, payroll, taxes, and interest of (9 M). | |
| Cingulate currently holds about 8.2 M in cash with (15.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73. | |
| Cingulate has a frail financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Acquisition by Lawrence Bryan Jay of 5000 shares of Cingulate at 1.18 subject to Rule 16b-3 |
Cingulate Returns Distribution Density
The distribution of Cingulate's historical returns is an attempt to chart the uncertainty of Cingulate's future price movements. The chart of the probability distribution of Cingulate daily returns describes the distribution of returns around its average expected value. We use Cingulate price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Cingulate returns is essential to provide solid investment advice for Cingulate.
| Mean Return | -0.8 | Value At Risk | -10.28 | Potential Upside | 9.27 | Standard Deviation | 7.82 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cingulate historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Cingulate Stock Institutional Investors
| Shares | Geode Capital Management, Llc | 2024-09-30 | 0.0 | Jpmorgan Chase & Co | 2024-06-30 | 0.0 | Armistice Capital, Llc | 2024-09-30 | 0.0 | Advisor Group Holdings, Inc. | 2024-06-30 | 0.0 | Hrt Financial Llc | 2024-06-30 | 0.0 | Commonwealth Equity Services Inc | 2024-06-30 | 110.3 K | Bank Of America Corp | 2024-06-30 | 22.5 K | Virtu Financial Llc | 2024-06-30 | 20.2 K | Fmr Inc | 2024-09-30 | 352 | Qube Research & Technologies | 2024-06-30 | 100.0 | Alphamark Advisors, Llc | 2024-09-30 | 10.0 |
Cingulate Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cingulate or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cingulate's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cingulate stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.93 | |
β | Beta against Dow Jones | 0.97 | |
σ | Overall volatility | 7.54 | |
Ir | Information ratio | -0.12 |
Cingulate Volatility Alert
Cingulate is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Cingulate's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Cingulate's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Cingulate Fundamentals Vs Peers
Comparing Cingulate's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Cingulate's direct or indirect competition across all of the common fundamentals between Cingulate and the related equities. This way, we can detect undervalued stocks with similar characteristics as Cingulate or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Cingulate's fundamental indicators could also be used in its relative valuation, which is a method of valuing Cingulate by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Cingulate to competition |
| Fundamentals | Cingulate | Peer Average |
| Return On Equity | -2.74 | -0.31 |
| Return On Asset | -1.04 | -0.14 |
| Current Valuation | 5.29 M | 16.62 B |
| Shares Outstanding | 3.21 M | 571.82 M |
| Shares Owned By Insiders | 3.30 % | 10.09 % |
| Shares Owned By Institutions | 2.29 % | 39.21 % |
| Number Of Shares Shorted | 89.24 K | 4.71 M |
| Price To Book | 1.25 X | 9.51 X |
| Gross Profit | (9 M) | 27.38 B |
| EBITDA | (22.95 M) | 3.9 B |
| Net Income | (23.53 K) | 570.98 M |
| Cash And Equivalents | 8.2 M | 2.7 B |
| Cash Per Share | 0.73 X | 5.01 X |
| Total Debt | 3.14 M | 5.32 B |
| Debt To Equity | 0.08 % | 48.70 % |
| Current Ratio | 10.94 X | 2.16 X |
| Book Value Per Share | 6.82 X | 1.93 K |
| Cash Flow From Operations | (15.04 M) | 971.22 M |
| Short Ratio | 0.87 X | 4.00 X |
| Earnings Per Share | (43.22) X | 3.12 X |
| Target Price | 48.33 | |
| Number Of Employees | 13 | 18.84 K |
| Beta | -0.91 | -0.15 |
| Market Capitalization | 15.1 M | 19.03 B |
| Total Asset | 3.49 M | 29.47 B |
| Retained Earnings | (92.94 M) | 9.33 B |
| Working Capital | 856.85 K | 1.48 B |
| Net Asset | 3.49 M |
Note: Acquisition by Lawrence Bryan Jay of 5000 shares of Cingulate at 1.18 subject to Rule 16b-3 [view details]
Cingulate Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Cingulate . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Cingulate Buy or Sell Advice
When is the right time to buy or sell Cingulate? Buying financial instruments such as Cingulate Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Cingulate in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Insurance Thematic Idea Now
Insurance
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Insurance theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Insurance Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Cingulate Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cingulate. If investors know Cingulate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cingulate listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (43.22) | Return On Assets (1.04) | Return On Equity (2.74) |
The market value of Cingulate is measured differently than its book value, which is the value of Cingulate that is recorded on the company's balance sheet. Investors also form their own opinion of Cingulate's value that differs from its market value or its book value, called intrinsic value, which is Cingulate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cingulate's market value can be influenced by many factors that don't directly affect Cingulate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cingulate's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cingulate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cingulate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.